產品分類
Product Category
CHIR-99021 (CT99021) HCl 1797989-42-4 CHIR-99021 monohydrochloride is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM; 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2,
Zoldonrasib(RMC-9805)是一類有效、first-in-class 的小分子共價抑制劑,特異性靶向激活態(GTP-bound,ON)KRAS G12D突變蛋白,屬于創新型三元復合體(tri-complex)RAS (ON) 抑制劑。產品由 Revolution Medicines 開發,目前處于臨床 I/II 期,用于 KRAS G12D 突變實體瘤(胰腺癌、結直腸癌、非小細胞
Daraxonrasib(RMC-6236)是有效的新型三元復合物型泛活化態 RAS(RAS (ON))多選擇性抑制劑,可強效非共價結合 GTP 結合態的多種 RAS 突變體(包括 KRAS、NRAS、HRAS 的野生型及 G12X/G13X/Q61X 等突變體),阻斷 RAS 與下游效應蛋白的相互作用,抑制 ERK 磷酸化,從而發揮抗腫瘤活性。本品為科研級試劑,適用于 RAS
DNQX 2379-57-9 is a non-N-methyl-D-aspartate (non-NMDA) receptor complex antagonist.
Cyclosporin A 59865-13-3 CyclosporinA是一種免疫抑制劑,與親環素結合,隨后抑制calcineurin,無細胞試驗中IC50為7nM,廣泛用于預防器guan移植反應中的排斥反應。
CNQX disodium salt 479347-85-8 CNQX disodium salt is a potent and competitive GluR (kainate/quisqualate (non-NMDA) receptor) antagonist.
CNQX 115066-14-3 CNQX (FG9065) 是高效的 AMPA/kainate 受體拮抗劑。
CHIR-99021 trihydrochloride 1782235-14-6 CHIR-99021 trihydrochloride is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM;